Isracann Biosciences Stock Price on November 6, 2024

If you're considering investing in Isracann Pink Sheet, it is important to understand the factors that can impact its price. Isracann Biosciences holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13% return per unit of risk over the last 3 months. Isracann Biosciences exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement.
  
Isracann Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.126

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsISCNF

Estimated Market Risk

 12.6
  actual daily
96
96% of assets are less volatile

Expected Return

 -1.59
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.13
  actual daily
0
Most of other assets perform better
Based on monthly moving average Isracann Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Isracann Biosciences by adding Isracann Biosciences to a well-diversified portfolio.

Related Headline

Collegium Pharmaceutical Headline on 6th of November 2024

Collegium Pharmaceutical Inc is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is 155.57 million, and th

Isracann Biosciences Valuation on November 6, 2024

It is possible to determine the worth of Isracann Biosciences on a given historical date. On November 6, 2024 Isracann was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Isracann Biosciences pink sheet. Still, in general, we apply an absolute valuation method to find Isracann Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Isracann Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Isracann Biosciences' related companies.
 Open High Low Close Volume
  0.0001    0.0001    0.0001    0.0001    1.00  
11/06/2024
  0.0001    0.0001    0.0001    0.0001    1.00  
  0.0001    0.0001    0.0001    0.0001    300.00  
Backtest Isracann Biosciences  |  Isracann Biosciences History  |  Isracann Biosciences Valuation   PreviousNext  
Open Value
1.0E-4
1.0E-4
Closing Value
37.80
Upside

Isracann Biosciences Trading Date Momentum on November 6, 2024

On November 07 2024 Isracann Biosciences was traded for  0.0001  at the closing time. The highest daily price throughout the period was 0.0001  and the lowest price was  0.0001 . The daily volume was 300. The net trading volume on 11/07/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% .

Isracann Biosciences Fundamentals Correlations and Trends

By evaluating Isracann Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Isracann Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Isracann financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Isracann Biosciences Pink Sheet history

Isracann Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Isracann is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Isracann Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Isracann Biosciences stock prices may prove useful in developing a viable investing in Isracann Biosciences
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States.

Isracann Biosciences Pink Sheet Technical Analysis

Isracann Biosciences technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Isracann Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Isracann Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Isracann Biosciences Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Isracann Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Isracann Biosciences December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Isracann Biosciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Isracann Biosciences shares will generate the highest return on investment. By undertsting and applying Isracann Biosciences pink sheet market strength indicators, traders can identify Isracann Biosciences entry and exit signals to maximize returns

Complementary Tools for Isracann Pink Sheet analysis

When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account